Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

COVID-19 lab-leak theory re-emerges as U.S. intelligence report surfaces

By Brian Buntz | May 24, 2021

SARS-CoV-2 COVID-19

This colorized scanning electron microscope image shows SARS-CoV-2 (round blue objects), the virus that causes COVID-19, emerging from the surface of cells cultured in the lab. [Image courtesy of National Institute of Allergy and Infectious Diseases]

A previously undisclosed U.S. intelligence report revealed that three scientists from China’s Wuhan Institute of Virology became sick enough in November 2019 to seek hospital care, according to the Wall Street Journal.

The illnesses were consistent with both COVID-19 and common seasonal illnesses, but the report fuels speculation that the scientists at the Wuhan lab were among the first to contract the SARS-CoV-2 virus. 

The disclosures have heightened calls for an independent probe into the origin of the pandemic because the Wuhan Institute of Virology has researched coronaviruses. The time frame of the workers’ hospital visits coincided with the beginning of human-to-human transmission of the virus in Wuhan. Researchers confirmed the first case of the virus on Dec. 8, 2019. 

The World Health Organization (WHO) has not entirely dismissed the lab-leak hypothesis but has concluded that it is “extremely unlikely.” The WHO is, however, continuing to investigate the pandemic’s origins. 

The Wuhan Institute of Virology has not made raw data, safety logs and lab records available pertaining to its research on bat coronaviruses. Wang Yanyi, the lab director, has dismissed such theories as ‘pure fabrication’ in 2020. Yanyi said the lab received the first report of unknown pneumonia on Dec. 30, 2019, and that the lab had never encountered the virus before. “How could it have leaked from our lab when we never had it?” she asked. 

China’s U.S. embassy dismissed the possibility that the Wuhan Institute of Virology was the source of the virus, pointing to a statement from the institute from March 23 stating that it had not been exposed to COVID-19 before December 30, 2019. Furthermore, the institute said it has kept a “zero-infection” record for its staff and graduate students.

“This January, the China-WHO joint mission made field trips to institutions including the Hubei Provincial Center for Disease Control, the Wuhan Center for Disease Control and the Wuhan Institute of Virology, and visited biosafety laboratories and had in-depth and candid exchanges with experts there,” said Chinese Foreign Ministry’s spokesperson Zhao Lijian. WHO members unanimously agreed that the lab leak scenario was doubtful through these field trips and visits, Lijian said. “Member of the joint mission Peter Daszak said during an interview with American media that they were able to have in-depth exchanges with authoritative experts in the Wuhan Institute of Virology with a level of openness even he hadn’t anticipated, when the claim of lab leaking was politicized on a global scale,” Lijian said.

Lijian also highlighted that the possibility that the virus first emerged outside of China. “Meanwhile, I also want to point out that there are increasingly more reports on the virus and COVID-19 pandemic being spotted in various places around the world early in the second half of 2019, and that the international community is highly concerned about the questions around the biological lab at Fort Detrick and the real intentions of the U.S. establishment of 200-plus overseas bio-labs,” he said.

Chinese authorities have questioned the U.S.’s willingness to entertain the lab-leak scenario. “We hope that the relevant departments in the U.S. will make a clarification and explain [its position] to the world as soon as possible,” Lijian said.

A spokeswoman for the National Security Council recently told the Wall Street Journal that the U.S. government has “serious questions about the earliest days of the Covid-19 pandemic, including its origins within the People’s Republic of China,” but that the government was still unsure about the source of the pandemic. 

Former FDA Commissioner Dr. Scott Gottlieb recently told CNBC that he believes there is growing circumstantial evidence that the virus leaked from a lab. “The question for a lot of people is going to be when are too many coincidences too much? When does it just seem that there are too many things suggesting that this could have come out of a lab?” he asked.

Gottlieb said that it would likely be impossible to confirm if the virus did emerge from a lab. “If there were retained samples from those people who were infected in that lab, I don’t think they are available anymore,” he said.

Chinese officials have highlighted the possibility that the pandemic may have originated outside of Wuhan. They have called for an investigation into early COVID-19 outbreaks outside of its borders. Beijing has argued that the virus may have first emerged from the Fort Detrick army base in Maryland. Facilities there focus on biological defense. 


Filed Under: Infectious Disease
Tagged With: coronavirus, covid-19, SARS-CoV-2
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

covid-19 vaccine
FDA COVID booster pullback jolts vaccine stocks before gains cool
Coronavirus Covid-19 background - 3d rendering
Pregnancy associated with less long COVID: Researchers call for studies on protective biology
How technology advances are helping scientists unlock the mysteries of zoonotic diseases
Novel coronovirus
Advances in next generation vaccine development for SARS-CoV-2
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE